ZetrOZ Systems inked a five-year healthcare federal supply schedule agreement to provide U.S. government healthcare institutes with its sustained acoustic medicine (SAM) device and hypoallergenic ultrasound coupling patches.

The $3.4 million contract covers hospitals and military bases, veteran healthcare hospitals, and employees of the FBI, CIA, DOL, postal service, and other U.S. departments and agencies operating both in the United States and abroad.

“We’re proud to play our part in getting and keeping our federal employees healthy and returning them to work fully healed and pain-free,” says ZetrOZ CEO George Lewis, PhD. “The sam device product family of healing innovation is increasingly getting recognized for its success in helping professional athletes, combat veterans, and countless others in soft-tissue injury healing. So much credit goes to the U.S. government for bringing this effective and practical treatment option to its hardworking employees.”

Military veterans, federal agents, and postal workers have a greater rate of injury and chronic pain than the general population, contending not only with damage from acute injury but also with repetitive stress damage caused by the physical demands of the job. ZetrOZ Systems’ portfolio of wearable, drug-free, non-invasive devices are designed to deliver long-duration ultrasound to activate the body’s healing multiple hours each day. 

The agreement provides another channel for healthcare providers to prescribe and use SAM for the treatment of common overuse injuries like the rotator cuff, knee injury, tendonitis etc. Providers and hospital centers can order SAM directly through the new contract and through the ZetrOZ Systems Durable Medical Equipment healthcare network directly.

ZetrOZ’s SAM therapy for home use is already benefiting veterans in both postoperative recovery and longer-term management of painful conditions like osteoarthritis.

ZetrOZ Systems has shown that daily, sustained acoustic medicine accelerates soft tissue healing and provides symptomatic relief of knee pain related to osteoarthritis (OA) and back pain related to herniated disks.

A 2020 study in the Global Journal of Orthopedics Research found 87% of users demonstrated improved function after use of the ZetrOZ SAM device. Another study in 2021 from Current Orthopedic Practice demonstrated high confidence in SAM to accelerate the healing of overuse injuries.